Gilead Sciences
GILD
1,626 hedge funds and large institutions have $76.4B invested in Gilead Sciences in 2020 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 632 increasing their positions, 682 reducing their positions, and 161 closing their positions.
2% more capital invested
Capital invested by funds: $75B → $76.4B (+$1.42B)
0% more first-time investments, than exits
New positions opened: 161 | Existing positions closed: 161
0% less call options, than puts
Call options by funds: $2.02B | Put options by funds: $2.02B
0.7% less ownership
Funds ownership: 79.98% → 79.28% (-0.7%)
7% less repeat investments, than reductions
Existing positions increased: 632 | Existing positions reduced: 682
1% less funds holding
Funds holding: 1,644 → 1,626 (-18)
56% less funds holding in top 10
Funds holding in top 10: 89 → 39 (-50)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$2.25B |
| 2 |
BlackRock
New York
|
+$1.12B |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
+$473M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$130M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
+$127M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$499M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$465M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$378M |
| 4 |
JP Morgan Chase
New York
|
-$331M |
| 5 |
Renaissance Technologies
New York
|
-$278M |
GILD Hedge Fund Activity: Q2 2020 in Review
1,626 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2020, worth a combined $76.4B — up 1.9% from $75B a quarter earlier.
Fund positioning in GILD was balanced in Q2 2020: 161 funds opened new positions, 161 closed out, 632 added to existing stakes and 682 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $2.25B. The largest seller was Franklin Resources, cutting an estimated $499M.
- 1,626 institutional investors held Gilead Sciences (GILD) as of Q2 2020, down from 1,644 in Q1 2020.
- Funds reported $76.4B of Gilead Sciences stock for Q2 2020, up 1.9% quarter-over-quarter.
- 161 funds opened new Gilead Sciences positions in Q2 2020 and 161 closed out, a net change of 0 holders.
- The largest Gilead Sciences buyer in Q2 2020 was Capital Research Global Investors, an estimated $2.25B added.
- The largest Gilead Sciences seller in Q2 2020 was Franklin Resources, an estimated $499M sold.
Based on aggregated 13F filings for Q2 2020.